Tricyclic heteroaromatic systems. Synthesis and benzodiazepine receptor affinity of 2-substituted-1-benzopyrano [3,4-d] oxazol-4-ones, -thiazol-4- ones, and -imidazol-4-ones

Farmaco

Volumn 53, Issue 5, 1998, Pages 375-381

  Colotta, Vittoria ^a   Catarzi, Daniela ^a   Varano, Flavia ^a   Cecchi, Lucia ^a   Filacchioni, Guido ^a   Martini, Claudia ^b   Giusti, Laura ^b   Lucacchini, Antonio ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

1 Benzopyrano 3,4 d oxazol 4 ones; 1 Benzopyrano 3,4 d thiazol 4 ones; 1 Benzopyrano 3,4 d imidazol 4 ones; Benzodiazepine receptor activity

Indexed keywords

1 BENZOPYRANO[3,4 D]OXAZOL 4 ONE DERIVATIVE; BENZODIAZEPINE RECEPTOR; BENZOPYRAN DERIVATIVE; TRICYCLIC AROMATIC COMPOUND; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CATTLE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; NONHUMAN; STRUCTURE ACTIVITY RELATION;

EID: 0032580691     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00028-7     Document Type: Article

References (23)

1. [1] R. Squires (Ed.), GABA and Benzodiazepine Receptors, vols. I and II, CRC Press, Boca Raton, FL, 1988.
2. [2] W.E. Haefely, M. Facklam, P. Schoch, J.R. Martin, E.P. Bonetti, J.L. Moreau, F. Jenck, G. Richards, Adv. Biochem. Psychopharmacol. 47 (1992) 379-394.
3. [3] W.E. Haefely, J.R. Martin, G. Richards, P. Schoch, Can. J. Psychiatr. 38 (Suppl. 4) (1993) S102-S107.
4. [4] E. Costa, A. Guidotti, Trends Pharmacol. Sci. 17 (1996) 192-200.
5. [5] J.A. Miller, M.W. Dudley, JH. Kehne, S.M. Sorensen, J.M. Kane, Br. J. Pharmacol. 107 (1992) 78-86.
6. [6] D. Catarzi, L. Cecchi, V. Colotta, F. Melani, G. Filacchioni, C. Martini, L. Giusti, A. Lucacchini, Farmaco 48 (1993) 1065-1078.
7. [7] D. Catarzi, L. Cecchi, V. Colotta, G. Filacchioni, C. Martini, L. Giusti, A. Lucacchini, Farmaco 49 (1994) 89-92.
8. [8] D. Catarzi, L. Cecchi, V. Colotta, G. Filacchioni, F. Varano, C. Martini, L. Giusti, A. Lucacchini, J. Med. Chem. 38 (1995) 2196-2201.
9. [9] V. Colotta, D. Catarzi, F. Varano, F. Melani, G. Filacchioni, L. Cecchi, A. Galli, C. Costagli, Farmaco 51 (1996) 223-229.
10. [10] V. Colotta, D. Catarzi, F. Varano, G. Filacchioni, L. Cecchi, A. Galli, C. Costagli, J. Med. Chem. 39 (1996) 2915-2921.
11. [11] F. Varano, D. Catarzi, V. Colotta, L. Cecchi, G. Filacchioni, A. Galli, C. Costagli, Arch. Pharm. Pharm. Med. Chem. 329 (1996) 529-534.
12. [12] Neurogen Corporation, US Patent 5 182 290 (1993) [Chem. Abstr. 119 (1993) 49380p].
13. [13] C.F. Huebner, K.P. Link, J. Am. Chem. Soc. 67 (1945) 99-102.
14. [14] O.A. Ponomaref, Yu.N. Brasil'tsev, V.Kh. Grif, V.G. Mitina, Ukr. Khim. Zh. (Russ. ed.) 56 (1990) 272-276 [Chem. Abstr. 113 (1990) 132057k].
15. [14] O.A. Ponomaref, Yu.N. Brasil'tsev, V.Kh. Grif, V.G. Mitina, Ukr. Khim. Zh. (Russ. ed.) 56 (1990) 272-276 [Chem. Abstr. 113 (1990) 132057k].
16. [15] J.R. Merchant, S.S. Shirali, Chem. Ind. (London) (1977) 33.
17. [16] L. Reppel, W. Schmollack, Arch. Pharm. (Weinheim) 296 (1963) 365-399.
18. [17] T.Ya. Mozhaeva, V.N. Drozd, V.N. Knyazev, V.L. Savel'ev, V.P. Lezina, Zh. Org. Khim. (Russ. ed.) 26 (1990) 1597-1598.
19. [18] V.L. Savel'ev, O.S. Artamonova, V.A. Zagorevskii, Khim. Geterosikl. Soedin. (Russ. ed.) (1976) 316-320.
20. [19] G. Giannaccini, M. Giacomelli, C. Martini, A. Lucacchini, M. Piccolino, Comp. Biochem. Physiol. C 101 (1992) 337-342.
21. [20] C. Martini, A. Lucacchini, G. Ronca, S. Hrelia, C.A. Rossi, J. Neurochem. 38 (1982) 15-19.
22. [21] C. Martini, T. Rigacci, A. Lucacchini, J. Neurochem. 41 (1983) 1183-1185.
23. [22] D.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 193 (1951) 265-275.